These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6230897)

  • 1. A double-blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders.
    Merideth CH; Feighner JP
    Acta Psychiatr Scand Suppl; 1983; 308():70-9. PubMed ID: 6230897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre double-blind comparative trial of zimeldine and imipramine in primary major depressive disorders.
    Hiramatsu KI; Takahashi R; Mori A; Inoue R; Kazamatsuri H; Murasaki M; Sakuma A
    Acta Psychiatr Scand Suppl; 1983; 308():41-54. PubMed ID: 6230895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zimeldine versus nomifensine. A double-blind study of depressed inpatients.
    Knudsen P; Bjørndal N; Johnsen T; Pfeiffer Petersen K
    Neuropsychobiology; 1984; 11(4):236-42. PubMed ID: 6238240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.
    Evans L; Kenardy J; Schneider P; Hoey H
    Acta Psychiatr Scand; 1986 Jan; 73(1):49-53. PubMed ID: 2938422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zimeldine tolerability in comparison to amitriptyline and placebo: findings from a multicentre trial.
    Claghorn J; Gershon S; Goldstein BJ
    Acta Psychiatr Scand Suppl; 1983; 308():104-14. PubMed ID: 6230883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
    Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
    J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
    Kasper S; Möller HJ; Montgomery SA; Zondag E
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zimeldine versus amitriptyline in endogenous depression. A double-blind study with special reference to effects on liver function.
    Larsen FW; Hansen CE
    Acta Psychiatr Scand; 1984 Apr; 69(4):343-9. PubMed ID: 6232828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB; Varga L; Lyford A
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between zimeldine and amitriptyline of efficacy and adverse symptoms--a combined analysis of four British clinical trials in depression.
    Huitfeldt B; Montgomery SA
    Acta Psychiatr Scand Suppl; 1983; 308():55-69. PubMed ID: 6230896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of zimeldine in preventing depressive episodes in recurrent major depressive disorders--a double-blind placebo-controlled study.
    Björk K
    Acta Psychiatr Scand Suppl; 1983; 308():182-9. PubMed ID: 6230892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zimeldine in depressive illness--efficacy and safety data.
    Burrows GD; Norman TR; Marriott PF; Davies B
    Acta Psychiatr Scand Suppl; 1983; 308():31-40. PubMed ID: 6230894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive offsodes.
    Berzewski H; Van Moffaert M; Gagiano CA
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S37-47; discussion S71-3. PubMed ID: 9169309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
    Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W
    Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
    Feighner JP; Meredith CH; Frost NR; Chammas S; Hendrickson G
    Acta Psychiatr Scand; 1983 Oct; 68(4):223-33. PubMed ID: 6138925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder.
    Cohn JB; Collins G; Ashbrook E; Wernicke JF
    Int Clin Psychopharmacol; 1989 Oct; 4(4):313-22. PubMed ID: 2607128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R; Márquez CA; Traballi CA; Portes N
    Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.